Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral aspergillosis].

P Tattevin1, S Jauréguiberry, J-P Gangneux

  • 1Service des Maladies Infectieuses et Réanimation Médicale, CHU Pontchaillou, Rennes. pierre.tattevin@chu-rennes.fr

Revue Neurologique
|July 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world daptomycin use with a focus on muscle toxicity: A multicentric retrospective study.

International journal of antimicrobial agents·2026
Same author

Compassionate Use of Olorofim for Invasive Mold Infections: A Nationwide Observational Study in France.

Open forum infectious diseases·2026
Same author

Guidelines for Lyme borreliosis: treatment.

Infectious diseases now·2025
Same author

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

IJTLD open·2025
Same author

Influenza and pneumococcal vaccine coverage among adults hospitalized with acute respiratory infection in France: A prospective cohort study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Brain aspergillosis, a severe fungal infection, is increasingly diagnosed in immunocompromised patients. Early suspicion, improved diagnostics like Aspergillus antigenemia testing, and newer treatments like voriconazole enhance patient outcomes.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Mycology

Context:

  • Brain aspergillosis is a severe opportunistic infection, often originating from pulmonary aspergillosis via hematogenous spread.
  • Its incidence is rising due to increased use of immunosuppressive therapies.
  • The condition frequently affects the thalamus and basal nuclei due to vascular tropism, causing cerebral vasculitis.

Purpose:

  • To highlight the diagnostic and therapeutic advancements in brain aspergillosis.
  • To emphasize the importance of early diagnosis and appropriate management.
  • To discuss the clinical features and risk factors associated with this infection.

Summary:

  • Brain aspergillosis presents with specific neurological lesions and is associated with risk factors for invasive aspergillosis, persistent fever, and respiratory symptoms.

Related Experiment Videos

  • Aspergillus antigenemia testing offers a valuable non-invasive diagnostic approach.
  • Voriconazole demonstrates superior efficacy and tolerance compared to amphotericin B for invasive aspergillosis, particularly in CNS involvement.

    • Impact:

    • Improved diagnostic accuracy through antigenemia testing.
    • Enhanced patient survival and clinical response with voriconazole therapy.
    • Facilitates earlier detection and intervention, improving prognosis for a severe emerging infection.